Majority experienced a clinically meaningful
improvement in stress and sleep quality, and a significant 74%
average improvement in well-being
DENVER,
Feb. 8, 2022
/PRNewswire/ - (TSX:CWEB) (OTCQX:CWBHF) Charlotte's Web Holdings,
Inc. ("Charlotte's Web" or the "Company"), the market leader in
cannabidiol (CBD) hemp extract wellness products, shares the
positive results from a randomized, controlled, clinical trial
study which evaluated the effectiveness of hemp-derived CBD
extracts. Charlotte's Web participated in the Radicle ACES
(Advancing CBD Education and Science) study, conducted by Radicle
Science, an independent health tech company validating health and
wellness products. As part of a larger study, hundreds of
participants from across the US used Charlotte's Web Original
Formula for four weeks and were assessed for key health outcomes
across five domains including general well-being, quality of life,
sleep quality, feelings of daily stress or discomfort. Researchers
conducted the study using standardized scientific methods and
validated indices for measuring each outcome and tracked their
progress repeatedly throughout the study.
"As a hemp company driven by sound science, we were encouraged
by the Radicle Science study," Charlotte's Web President of CW
Labs' Tim Orr said. "Independent
third-party research and reporting on the efficacy of hemp wellness
products help build long term consumer trust and is an ongoing
commitment of Charlotte's Web."
"We're applying modern science to prove or predict
the effectiveness of CBD products used by tens of millions of
Americans every day," said Jeff
Chen, MD/MBA, Co-founder and CEO of Radicle Science. "Our
objective is to deliver accurate, transparent, and actionable
insights to help create trust and transparency for the CBD
industry."
People in the study regularly taking Charlotte's Web Original
Formula on average realized a distinct and palpable improvement in
their quality of life and well-being. A majority of people also
experienced clinically meaningful improvements across the other
health domains studied including sleep quality and feelings of
daily stress or discomfort as compared to the baseline, before they
started taking Charlotte's Web. People on average showed
significant improvements as compared to the control group who did
not take any hemp extract.
This clinical trial helps confirm the benefits of Charlotte's
Web full spectrum hemp extract. 64% of participants with
symptoms of stress experienced clinically meaningful improvements
in their stress after taking Charlotte's Web Original Formula,
versus only 22% of the control group. 60% of participants
struggling with sleep issues experienced clinically meaningful
improvements in sleep quality, versus only 15% of the control
group. And participants who took Charlotte's Web experienced
a significant 74% improvement in their well-being assessed using
the World Health Organization (WHO)-5 Well Being Index. The study
also showed that Charlotte's Web worked quickly with notable
improvements on average occurring within the first week, and
generally reported effect onset within four hours after using the
product. The study is therefore helpful in addressing a common
question around hemp CBD: "How long will it take to work?"
"Charlotte's Web and other responsible participants in the CBD
industry continue prudent research investment to contribute data on
the safety and efficacy of hemp. This increases the standard of
trust and transparency for consumers, healthcare providers, and
regulators," said Jacques Tortoroli,
Chief Executive Officer of Charlotte's Web. "Our Original Formula
remains as effective today as when it was first developed by the
founding Stanley Brothers years ago
and took the world by storm. Consistency from year to year and
bottle to bottle is a core driver of the trust that Charlotte's Web
has earned."
"The rigor, large scale and intentional heterogeneity of our
studies deliver the first ever scalable path to validate the health
effects of health and wellness products," said Pelin
Thorogood, Co-founder and Executive Chair of Radicle Science. "We
are proud to partner with industry leaders such as Charlotte's
Web to inform evidence-based decision making for consumers, brands,
healthcare providers and regulators alike, increasing trust and
transparency for the CBD industry."
Subscribe to Charlotte's Web investor news.
About Radicle Science
Radicle Science is a
transformative health tech B-corp offering the first ever scalable
path to validate and predict the health effects of health and
wellness products, transforming them into democratized precision
solutions for ailments or enhancement of human function. Radicle
Science leverages a proprietary data analytics platform and a
virtual, direct-to-consumer (D2C) clinical trial model to deliver
objective health outcome data across diverse populations and
conditions, at a fraction of the cost and time of traditional
methods. Our Radicle Vision is a future where affordable,
accessible, consumer health products are trusted by patients,
recommended by healthcare providers, reimbursed by insurance, and
used as widely as pharmaceutical drugs. To learn more, please visit
www.radiclescience.com and follow their LinkedIn page and Twitter
page.
About Charlotte's Web Original Formula™
In 2013,
Colorado's seven Stanley Brothers famously developed a unique CBD
hemp extract to help a little girl (Charlotte Figi) in need, and changed global
perceptions around the wellness benefits of hemp. Charlotte's
Web Original Formula™ full spectrum CBD hemp extract – first used
by Charlotte Figi, the namesake of
the Company - has been credited with supporting numerous wellness
goals, improving lives, and launching a global CBD industry. The
2018 Farm Bill federally legalized hemp. Charlotte's Web is the
Worlds Most Trusted Hemp Extract™ and continues to lead the way for
consumer access. Since its founding, Charlotte's Web's mission
has been "To unleash the healing powers of botanicals with
compassion and science, benefiting the planet and all who live upon
it."
About Charlotte's Web Holdings, Inc.
Charlotte's Web
Holdings, Inc., a Certified B Corporation headquartered in
Denver, is the market leader in
innovative hemp extract wellness products under a family of brands
which includes Charlotte's Web™, CBD Medic™, CBD Clinic™, and
Harmony Hemp™. Charlotte's Web branded premium quality products
start with proprietary hemp genetics that are 100-percent American
farm grown and manufactured into hemp
extracts containing naturally
occurring phytocannabinoids including cannabidiol
("CBD"), CBC, CBG, terpenes, flavonoids, and other
beneficial hemp compounds. The Company's CW Labs R&D
division, advances hemp science at two centers of excellence in
Louisville, Colorado, and the
Hauptmann Woodward Research Institute at the University at Buffalo, part of the State University of New York (SUNY) network. Charlotte's Web product categories
include full-spectrum hemp CBD oil tinctures (liquid products), CBD
gummies (sleep, stress, exercise recovery), CBD capsules, CBD
topical creams and lotions, as well as CBD pet products for
dogs. Through its vertically integrated business model,
Charlotte's Web maintains stringent control over product quality
and consistency. Charlotte's Web products are distributed to more
than 14,000 retail, over 8,000 health care practitioners, and
online through the Company's website at www.CharlottesWeb.com.
Charlotte's Web is a science-driven and a socially and
environmentally conscious company. It is committed to using
business as a force for good and a catalyst for innovation.
Charlotte's Web donates a portion of its pre-tax earnings to
numerous charitable organizations in support of the greater
good.
Forward-Looking Information
Certain information in this news release constitutes
forward-looking statements and forward-looking information
(collectively, "forward-looking information"). In some cases, but
not necessarily in all cases, forward looking information can be
identified by the use of forward-looking terminology such as
"plans", "targets", "expects" or "does not expect", "is expected",
"an opportunity exists", "is positioned", "estimates", "intends",
"assumes", "anticipates" or "does not anticipate" or "believes", or
variations of such words and phrases or state that certain
actions, events or results "may", "could", "would", "might", "will"
or "will be taken", "occur" or "be achieved". In addition, any
statements that refer to expectations, projections or other
characterizations of future events or circumstances contain
forward-looking information. Specifically, this news release
contains forward-looking information relating to the Company's
expansion activities and growth strategy; the Company's
expectations regarding future cash flow and its financial position;
the results of cost saving efforts; the impact and results of the
Company's reorganization; market share expectations; and impacts of
regulatory changes.
Statements containing forward-looking information are not
historical facts but instead represent management's current
expectations, estimates and projections regarding the future of
our business, future plans, strategies, projections, anticipated
events and trends, the economy and other future conditions.
Forward-looking information is necessarily based on a number of
opinions, assumptions and estimates that, while considered
reasonable by the Company as of the date of this news release, are
subject to known and unknown risks, uncertainties, assumptions and
other factors that may cause the actual results, level of activity,
performance or achievements to be materially different from those
expressed or implied by such forward-looking information. Important
factors that could cause actual results and financial condition to
differ materially from those indicated in the forward-looking
information include, among others, the factors discussed throughout
the "Risk Factors" section of the Company's most recently filed
annual information form available on www.SEDAR.com and in the
Company's most recently filed Form 10, as amended, and other
filings with the Securities and Exchange Commission available on
www.SEC.com. Except as required by applicable securities laws, the
Company undertakes no obligation to publicly update any
forward-looking information, whether written or oral, that may be
made from time to time, whether as a result of new information,
future developments or otherwise.
Charlotte's Web Holdings, Inc.
THE WORLD'S MOST TRUSTED HEMP EXTRACT™
View original content to download
multimedia:https://www.prnewswire.com/news-releases/clinical-trial-shows-charlottes-web-hemp-extracts-positive-effects-on-stress-sleep-and-well-being-301477910.html
SOURCE Charlotte's Web Holdings, Inc.